O
MGLN

OrbiMed’s Magellan Health Services, Inc. MGLN Stock Holding History

OrbiMed’s Portfolio MGLN Stock Details MGLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-251,383
Closed -$24.1M – 163
2018
Q2 		$24.1M Sell
251,383
-312,460
-55% -$30M 0.29% 81
2018
Q1 		$60.4M Sell
563,843
-292,000
-34% -$29.3M 0.75% 44
2017
Q4 		$82.6M Sell
855,843
-26,757
-3% -$2.37M 1.05% 29
2017
Q3 		$76.2M Sell
882,600
-332,500
-27% -$26.2M 0.73% 40
2017
Q2 		$88.6M Buy
1,215,100
+126,373
+12% +$8.88M 0.93% 36
2017
Q1 		$75.2M Buy
1,088,727
+287,127
+36% +$21M 0.85% 39
2016
Q4 		$60.3M Buy
801,600
+101,900
+15% +$6.52M 0.77% 40
2016
Q3 		$37.6M Sell
699,700
-390,900
-36% -$23.6M 0.43% 60
2016
Q2 		$71.7M Sell
1,090,600
-818,400
-43% -$55.1M 0.75% 45
2016
Q1 		$130M Buy
1,909,000
+76,000
+4% +$4.57M 1.36% 25
2015
Q4 		$113M Hold
1,833,000
– – 1.02% 33
2015
Q3 		$102M Buy
1,833,000
+382,300
+26% +$23.1M 1.03% 36
2015
Q2 		$102M Buy
1,450,700
+35,900
+3% +$2.44M 0.85% 36
2015
Q1 		$100M Buy
1,414,800
+206,800
+17% +$13M 0.86% 36
2014
Q4 		$72.5M Buy
1,208,000
+805,400
+200% +$47.6M 0.69% 39
2014
Q3 		$22M Buy
+402,600
New +$23.1M 0.23% 72

Other funds holding MGLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OrbiMed's MGLN Position: Q3 2018 in Review

OrbiMed sold out of Magellan Health Services, Inc. (MGLN) in Q3 2018, closing a stake of 251,383 shares — an estimated $24.1M sold.

OrbiMed first reported a position in MGLN in Q3 2014 and held it in 16 quarters. The position peaked at $130M in Q1 2016. 210 funds tracked by Wall St. Rank hold MGLN as of Q3 2018.

  • OrbiMed reported no remaining Magellan Health Services, Inc. position as of Q3 2018 after selling out during the quarter.
  • OrbiMed sold 251,383 Magellan Health Services, Inc. shares in Q3 2018, an estimated $24.1M.
  • OrbiMed first reported a position in Magellan Health Services, Inc. in Q3 2014 and held it in 16 quarters.
  • OrbiMed's Magellan Health Services, Inc. position peaked at $130M in Q1 2016.
  • 210 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q3 2018.

Based on OrbiMed's 13F filing for Q3 2018, filed 14 Nov 2018.